State of the Art: genetic assessment in dilated cardiomyopathy

28 August 2017 (14:00 - 14:18)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Luisa Mestroni

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

4 More presentations in this session

Presentation thumbnail

Defining the genetic architecture of dilated cardiomyopathy- insights from population genetic variation and the role of titin

Doctor U. Tayal (London, GB)

Presentation thumbnail

Comparison of genetic signature of isolated left ventricular non-compaction cardiomyopathy and familial dilated cardiomyopathy as assessed by whole exome sequencing.

Doctor M. Kubanek (Prague, CZ)

Abstract Slides Video

Presentation thumbnail

Yield of clinical and genetic cascade screening among 436 relatives of 111 consecutive index-patients with dilated cardiomyopathy

Doctor T. Hey (Odense, DK)

Abstract Slides Video

Presentation thumbnail

Dilated cardiomyopathy: from genetics to phenotype and prognosis

Professor B. Meder (Heidelberg, DE)

Access the full session

Session thumbnail

Dilated cardiomyopathy: the clinical relevance of genetic assessment

The Event

ESC Congress 2017

28 August 2017 14:00 CET

You may be interested in

Congress Presentation

Do the variables that the clinical cardiologist looks at when requesting a genetic study in the study of idiopathic dilated cardiomyopathy have predictive value?

29 June 2021

Congress Session

Risk stratification

30 March 2025

Congress Session

Risk assessment and prevention of sudden cardiac death in cardiomyopathies

11 May 2024

Webinar

Interpretation and actionability of genetic variants in cardiomyopathies

7 March 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources